Approaching Gold‐Standard Sensitivity in a Portable and Versatile Gold Nanoprisms Thermoplasmonic Platform for Lateral Flow Detection of Biomolecules
Small · 2026-07 · 22 (41)
DOI: 10.1002/smll.202514946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 30.05.2026. Verfasst von Carlos Cuestas Ayllón und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Nanociencia y Materiales De Aragón (INMA), Consejo Superior de Investigaciones Científicas (CSIC), University of Zaragoza, Zaragoza, Spa…. Hauptthemen laut MEDLINE: Gold, Metal Nanoparticles, Biosensing Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundació la Marató de TV3, Consejo Superior de Investigaciones Científicas, Fondo Social del Gobierno de Aragón.
Abstract (Originalsprache)
Plasmonic nanoparticles exhibit unique optical and thermal properties that make them ideal for next‐generation diagnostic technologies. Among them, gold nanoprisms (AuNPrs) are especially powerful due to their anisotropic geometry, tunable surface plasmon resonance in the near‐infrared (NIR) region, and high photothermal conversion efficiency. These features transform them from passive labels into active nanotransducers capable of amplifying diagnostic signals. Building on these advantages, we developed two AuNPr‐based sensing platforms: Thermo Lateral Flow Immunoassay (ThermoLFIA) and Thermo Oligonucleotide‐based Lateral Flow Assay (ThermoOLFA). By coupling AuNPrs with thermoresponsive substrates, both systems use localized heat generation to boost analytical sensitivity, enabling visual enhancement far beyond that of conventional gold spheres. ThermoLFIA demonstrated clinically relevant detection of gastrointestinal cancer biomarkers (CEA, CA19‐9, VEGF), outperforming standard ELISA tests. In parallel, functionalization of AuNPrs with DNA probes enabled ThermoOLFA to detect SARS‐CoV‐2 RNA with sensitivity comparable to RT‐qPCR, but without amplification steps and within 25 min. This proof‐of‐concept confirms that plasmonic nanoprisms can drive rapid, portable, and ultrasensitive diagnostics, opening a path toward point‐of‐care platforms with strong clinical and translational potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Nanociencia y Materiales De Aragón (INMA), Consejo Superior de Investigaciones Científicas (CSIC), University of Zaragoza, Zaragoza, Spain.
- Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto De Salud Carlos III, Madrid, Spain.
ORCID-Profile: Jesús Martínez de la Fuente
Förderung
- Fundació la Marató de TV3
- Consejo Superior de Investigaciones Científicas
- Fondo Social del Gobierno de Aragón
- Agencia Estatal de Investigación
Zitieren
APA
Ayllón, C. C., Barreiro, A. M., Barrientos, Á. G., Moros, M., Bonavía, V. G., & de la Fuente, J. M. (2026). Approaching Gold‐Standard Sensitivity in a Portable and Versatile Gold Nanoprisms Thermoplasmonic Platform for Lateral Flow Detection of Biomolecules. Small, 22(41). https://doi.org/10.1002/smll.202514946
Vancouver
Ayllón CC, Barreiro AM, Barrientos ÁG, Moros M, Bonavía VG, de la Fuente JM. Approaching Gold‐Standard Sensitivity in a Portable and Versatile Gold Nanoprisms Thermoplasmonic Platform for Lateral Flow Detection of Biomolecules. Small. 2026;22(41). doi:10.1002/smll.202514946
BibTeX
@article{Aylln2026,
author = {Ayllón, Carlos Cuestas and Barreiro, Alba Martín and Barrientos, África García and Moros, María and Bonavía, Valeria Grazú and de la Fuente, Jesús Martínez},
title = {Approaching Gold‐Standard Sensitivity in a Portable and Versatile Gold Nanoprisms Thermoplasmonic Platform for Lateral Flow Detection of Biomolecules},
journal = {Small},
year = {2026},
volume = {22},
number = {41},
doi = {10.1002/smll.202514946}
}
EUVIMED